|
Home
Live Seminars
About the Program
Quick Order
Hotel Registration
Auto Rental
Accreditation
Cancellation Policy
Testimonials
Video DVDs
MP3s/Audio CDs
Subscribe
Request Brochure
Hold Seat
Testing Online
Faculty
Resources
Contact Us
|
|
|
|
by Donald Kaye, M.D., M.A.C.P. - Drexel University, College of Medicine; Professor of Medicine, Philadelphia, PA; by Elaine T. Kaye, M.D. - Harvard Medical School; Assistant Professor, Division of Dermatology; Attending Physician, Children's Hospital Boston, MA; by Keith S. Kaye, M.D., M.P.H. - Wayne State University School of Medicine; Professor of Medicine; Corporate Medical Director, Hospital Epidemiology and Antimicrobial Stewardship, Detroit Medical Center, Detroit, MI; by Kenneth Kaye, M.D., F.A.C.P. - Harvard Medical School; Associate Professor of Medicine; Attending Physician, Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA and by Jerry Zuckerman, M.D. - Jefferson Medical College, Thomas Jefferson University; Assistant Professor of Medicine; Medical Director, Infection Prevention and Control, Division of Infectious Diseases, Albert Einstein Medical Center, Philadelphia, PA.
Learning Objectives
What do our past participants have to say?
Refer a Colleague to Our Website
|
|
Infectious Diseases in the Adult Patient: A Primary Care Update
December 29,30,31, 2008 and January 2, 2009
Location: Hyatt Regency Sarasota, Florida
OBJECTIVES
| OVERALL OBJECTIVES: The overall objective is to provide the participant with practical and clinically relevant information. Upon completion of this CME activity, the physician or healthcare provider should be able to describe the current approach to formulating differential diagnoses, diagnostic, therapeutic, and preventive management of the various disciplines presented. |
| SPECIFIC OBJECTIVES
| | Day 1 | New Endocarditis Prophylaxis Guidelines: What the PCP Needs to Know. - Upon completion of this session, the participant should be able to:
| 1. | Discuss current recommendations for antibiotic prophylaxis of endocarditis and prosthetic joints.
| | 2. | Describe data supporting prophylaxis.
| | 3. | Identify appropriate patients for prophylaxis.
| | 4. | Summarize proper administration of prophylactic antibiotics.
| | 5. | Identify proper prophylaxis in the allergic patient.
| | New or Emerging Infectious Diseases. - Upon completion of this session, the participant should be able to:
| | 1. | Explain the etiology and pathogenesis of these infections.
| | 2. | Describe the clinical approach and methods of diagnosing these infections.
| | 3. | Summarize the management of these infections.
| | Herpesvirus Infections. - Upon completion of this session, the participant should be able to:
| | 1. | List the clinically pertinent aspects of herpesvirus infections.
| | 2. | Describe the syndromes, clinical complications and attributes of recurrent disease.
| | 3. | Relate the proper management and use of anti-virals.
| | 4. | Viruses to be covered include:
| a. | Herpes simplex virus;
| | b. | Epstein-Barr virus;
| | c. | Cytomegalovirus;
| | d. | Varicella-zoster virus;
| | e. | HHV6.
|
| | Infective Diarrhea. - Upon completion of this session, the participant should be able to:
| | 1. | Differentiate the presentation of toxigenic and invasive diarrhea.
| | 2. | Identify food-borne pathogens.
| | 3. | Explain when to use fecal WBC, stool cultures, and stool O&P examinations.
| | 4. | Summarize the indications for antibiotic therapy.
| | 5. | Identify appropriate antibiotic choices.
| | Helicobacter pylori Infection. - Upon completion of this session, the participant should be able to:
| | 1. | Describe the clinical manifestations of H. pylori infection.
| | 2. | Relate the methods of diagnosing H. pylori infection.
| | 3. | Summarize the treatment of H. pylori infection.
|
| | Day 2 | Adult immunizations, Part I. - Upon completion of this session, the participant should be able to:
| 1. | Summarize the adult immunization schedule.
| | 2. | List recommendations for timing and spacing of immunobiologics.
| | 3. | Summarize indications, efficacy and current recommendations for the following vaccine preventable diseases: Influenza, pneumococcus and pertussis.
| | Hepatitis. - Upon completion of this session, the participant should be able to:
| | 1. | Explain the pathogenesis and clinical manifestations of hepatitis A, B, C, D or E.
| | 2. | Discuss differences in rates of complications.
| | 3. | Summarize treatment options for hepatitis B and C and their rates of success.
| | Adult Immunizations, Part II. - Upon completion of this session, the participant should be able to:
| | 1. | Summarize indications, efficacy and current recommendations for the following vaccine preventable diseases: Hepatitis A, hepatitis B, varicella-zoster, meningococcus and human papilloma virus.
| | 2. | Identify strategies to increase immunizations in adults.
| Common Skin and Nail Infections. - Upon completion of this session, the participant should be able to describe the pathogenesis, differential diagnosis, and therapy for a variety of common cutaneous infections as follows:
| 1. | Bacterial infections
| | 2. | Fungal infections
| | 3. | Viral infections
| | 4. | Nail infections and other nail abnormalities
| | 5. | Parasitic infestations
|
| | Community Acquired Pneumonia. - Upon completion of this session, the participant should be able to:
| | 1. | Identify the microbial causes of community acquired pneumonia.
| | 2. | Describe strategies utilized to triage patients to appropriate level of care.
| | 3. | Describe utility of current diagnostic tests.
| | 4. | Describe recommended treatment regimens.
|
| | Day 3 | Newer Antibacterial Agents. - Upon completion of this session, the participant should be able to:
| 1. | Relate the antibacterial spectrum of activity.
| | 2. | Describe the pharmacology of the agents.
| | 3. | List the indications and dosing recommendations.
| | 4. | Identify the side effects, adverse reactions and drug interactions.
| | Tuberculosis. - Upon completion of this session, the participant should be able to:
| | 1. | Identify groups at risk for developing active tuberculosis.
| | 2. | Describe the principles of antituberculous therapy.
| | 3. | Describe Mantoux technique for tuberculin skin testing.
| | 4. | Summarize indications for treatment of latent TB infection.
| | Update on Antimicrobial Resistance. - Upon completion of this session, the participant should be able to:
| | 1. | Describe the pattern of emergence of resistance to certain infecting bacteria.
| | 2. | Identify epidemiology that may indicate potential resistance among the organisms discussed such as:
| a. | Pneumococci;
| | b. | Enterococci;
| | c. | Gram negative bacilli.
|
| | 3. | Summarize the approach to current therapeutic regimens while considering resistance.
| | HIV Primer for the Primary Care Physician. - Upon completion of this session, the participant should be able to:
| | 1. | Discuss the latest epidemiology of HIV infection.
| | 2. | Describe recommendations for HIV screening.
| | 3. | Relate the utility of diagnostic tests (e.g. viral load, CD4 count) and their application for disease management.
| | 4. | Discuss the principles of antiretroviral treatment.
| | Methicillin Resistant Staphylococcus aureus (MRSA). - Upon completion of this session, the participant should be able to:
| | 1. | Describe the epidemiology of MRSA.
| | 2. | Describe important infections caused by MRSA.
| | 3. | Discuss and review risk factors and outcomes associated with MRSA.
| | 4. | Explain control and treatment of MRSA.
|
| | Day 4 | Urinary Tract Infection. - Upon completion of this session, the participant should be able to:
| 1. | Relate the epidemiology of UTIs.
| | 2. | Distinguish the attributes of lower tract and upper tract infections and reinfections and relapses.
| | 3. | Identify chronic bacterial prostatitis.
| | 4. | Describe the approach to antimicrobial therapy, to include the use of short course therapy.
| | 5. | Summarize the approach to prevention.
| | Cellulitis, Necrotizing Fasciitis and the Diabetic Foot Ulcers. - Upon completion of this session, the participant should be able to:
| | 1. | Explain typical and atypical manifestations.
| | 2. | Discuss the pathogenesis.
| | 3. | List the principles of medical and surgical treatment.
| | 4. | Describe the prognosis.
| | New Guidelines for STDs: Useful Information for the PCP. - Upon completion of this session, the participant should be able to:
| | 1. | Relate the current understanding of the epidemiology of common STDs.
| | 2. | Distinguish the attributes of clinical presentations.
| | 3. | Identify the diagnostic approaches.
| | 4. | Summarize the current treatment recommendations.
| | Meningitis and Meningoencephalitis. - Upon completion of this session, the participant should be able to:
| | 1. | Describe the epidemiology of meningitis and the different types of meningitis.
| | 2. | Identify clinical signs and symptoms of different types of meningitis.
| | 3. | Describe indications for lumbar puncture (LP) and interpretations of LP results.
| | 4. | Summarize treatment options and the need for hospitalization and public health notification.
| | Advice for the Traveler. - Upon completion of this session, the participant should be able to:
| | 1. | Summarize the general preventive measures including what not to eat and drink.
| | 2. | List the needed immunizations.
| | 3. | Describe the prevention of malaria, diarrhea and other illnesses of travelers.
| | 4. | Relate the management of diarrhea of travelers.
|
|
|